Mar 13
DRMA · Dermata Therapeutics, Inc. · Documents
$0.76
+0.00 (+0.28%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$3.07M
Shares
4.02M
Volume · Nov 6
60.22K
Avg daily vol (3M)
3.39M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2023
Mar 13
Registration statement
S-1/A
Registration statement
Mar 1
Registration statement
S-1
Registration statement
Feb 21
Current report
8-K
Financial results, Regulation FD disclosure
Feb 21
Feb 8
Current report
8-K
Shareholder vote results
Jan 13
Proxy statement
DEF 14A
Proxy statement
Jan 3
Proxy statement
PRE 14A
Proxy statement
2022
Dec 15
Current report
8-K
Delisting notice or listing transfer, Other events
Dec 5
Current report
8-K
Regulation FD disclosure, Other events
Nov 15
Registration statement
S-3
Registration statement
Nov 10
Current report
8-K
Financial results, Regulation FD disclosure
Nov 10
Sep 23
Current report
8-K
Events of Sep 21
Charter or bylaw amendment, or fiscal year change
Aug 15
Current report
8-K
Financial results, Regulation FD disclosure
Aug 15
Jul 11
Current report
8-K
Charter or bylaw amendment, or fiscal year change, Shareholder vote results
Jun 24
Current report
8-K
Events of Jun 21
Director or officer change, or executive pay
Jun 22
Current report
8-K
Events of Jun 17
Delisting notice or listing transfer
Jun 1
Proxy statement
DEF 14A
Meeting Jul 11, 2022
Proxy statement
Jun 1
Proxy statement
DEFA14A
Proxy statement
May 20
Proxy statement
PRE 14A
Proxy statement
May 17
Current report
8-K
Other events
May 16
Current report
8-K
Financial results, Regulation FD disclosure
May 16
May 4
Registration statement
S-1
Registration statement
Apr 25
Current report
8-K
Events of Apr 20
Entered into a material agreement, Unregistered sale of equity, Other events
Mar 28
Current report
8-K
Financial results, Regulation FD disclosure
Mar 28
Mar 2
Current report
8-K
Other events
Feb 7
Registration statement
S-1/A
Registration statement
Feb 4
Current report
8-K
Other events
Feb 4
Registration statement
S-1
Registration statement
Jan 13
Current report
8-K
Events of Jan 12
Director or officer change, or executive pay, Regulation FD disclosure
2021
Dec 10
Current report
8-K
Events of Dec 6
Director or officer change, or executive pay
Nov 19
Current report
8-K
Regulation FD disclosure, Other events
Nov 15
Current report
8-K
Financial results, Regulation FD disclosure
Nov 15
Sep 27
Current report
8-K
Financial results, Regulation FD disclosure
Sep 27
Sep 1
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
Aug 6
Registration statement
S-1/A
Registration statement
Jul 9
Registration statement
S-1/A
Registration statement
Jul 2
Registration statement
S-1/A
Registration statement
Jun 10
Registration statement
S-1
Registration statement
Showing 101–145 of 145 documents